Related references
Note: Only part of the references are listed.Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia
Janice McFarland et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Use and Safety of Unfractionated Heparin for Anticoagulation During Maintenance Hemodialysis
Jenny I. Shen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Anti-PF4/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients
Yueh-Feng Tsai et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Disappearance of Association in Diabetic Patients on Hemodialysis between Anemia and Mortality Risk: The Japan Dialysis Outcomes and Practice Pattern Study
Masaaki Inaba et al.
NEPHRON CLINICAL PRACTICE (2012)
Heparin-induced thrombocytopenia: analysis of risk factors in medical inpatients
Shumei Kato et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Clinical Practices and Outcomes in Elderly Hemodialysis Patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
Bernard Canaud et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Prevalence of heparin-induced antibody in African-American hemodialysis patients – comparison to non-dialysis patients
J. Benjamin et al.
CLINICAL NEPHROLOGY (2011)
Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia
Nicole L. Whitlatch et al.
BLOOD (2010)
Profiling of Heparin-Induced Thrombocytopenia Antibody Levels in Patients With and Without Diabetes
Josephina Diaz et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2010)
The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia
T. E. Warkentin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Effectiveness of a new immuno-assay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies
Claire Pouplard et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Antibodies to Heparin-Platelet Factor 4 Complex: Pathogenesis, Epidemiology, and Management of Heparin-Induced Thrombocytopenia in Hemodialysis
Andrew Davenport
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital
Makiko Ban-Hoefen et al.
THROMBOSIS RESEARCH (2009)
Treatment and prevention of heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
CHEST (2008)
Thrombocytopenia in Patients Treated with Heparin, Combination Antiplatelet Therapy, and Intra-Aortic Balloon Pump Counterpulsation
Heather R. Bream-Rouwenhorst et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2008)
Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays
T. E. Warkentin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis
Takefumi Matsuo et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2008)
Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes
A. Greinacher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
National survey of heparin-induced thrombocytopenia in the haemodialysis population of the UK population
Colin A. Hutchison et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Testing for heparin-induced thrombocytopenia antibodies
Theodore E. Warkentin et al.
TRANSFUSION MEDICINE REVIEWS (2006)
Heparin-induced thrombocytopenia
Gowthami M. Arepally et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis
Takefumi Matsuo et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2006)
Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?
TE Warkentin et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2005)
Risk for heparin-induced thrombocytopenia. with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
N Martel et al.
BLOOD (2005)
Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: A population-based study
LP de la Vega et al.
MAYO CLINIC PROCEEDINGS (2005)
Mechanistic Basis of Heparin-Induced Thrombocytopenia
Mortimer Poncz
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY (2005)
Dialyzer membrane permeability and survival in hemodialysis patients
P Chauveau et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
The pathophysiology of heparin-induced thrombocytopenia
JG Kelton
CHEST (2005)
Use of fondaparinux (ARIXTRA®) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II
M Haase et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis
I Palomo et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2005)
Treatment of heparin-induced thrombocytopenia - A critical review
J Hirsh et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
An overview of the heparin-induced thrombocytopenia syndrome
TE Warkentin
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2004)
Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis
SI O'Shea et al.
JOURNAL OF VASCULAR SURGERY (2003)
Frequency of anti-heparin-platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis
SI O'Shea et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Share Paper
